Adenosine deaminase deficiency and severe combined immunodeficiency disease.
D000225:Adenine / Q000378:metabolism; D000241:Adenosine / Q000494:pharmacology; D000243:Adenosine Deaminase / Q000172:deficiency* / Q000378:metabolism; D001402:B-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000201:enzymology* / Q000628:therapy; D008213:Lymphocyte Activation; D009700:Nucleoside Deaminases / Q000172:deficiency*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000150:complications / Q000628:therapy; D011687:Purines / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism; D012264:Ribonucleotide Reductases / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D014018:Tissue Distribution
D011687:Purines; D011743:Pyrimidines; D000242:Cyclic AMP; D012264:Ribonucleotide Reductases; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D000225:Adenine; D000241:Adenosine